[go: up one dir, main page]

ES2070087B1 - Derivados de indol - Google Patents

Derivados de indol

Info

Publication number
ES2070087B1
ES2070087B1 ES9301804A ES9301804A ES2070087B1 ES 2070087 B1 ES2070087 B1 ES 2070087B1 ES 9301804 A ES9301804 A ES 9301804A ES 9301804 A ES9301804 A ES 9301804A ES 2070087 B1 ES2070087 B1 ES 2070087B1
Authority
ES
Spain
Prior art keywords
indol
derivatives
compounds
useful
hypertensors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES9301804A
Other languages
English (en)
Other versions
ES2070087A1 (es
Inventor
John E Macor
Martin James Wythes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Priority to ES9301804A priority Critical patent/ES2070087B1/es
Publication of ES2070087A1 publication Critical patent/ES2070087A1/es
Application granted granted Critical
Publication of ES2070087B1 publication Critical patent/ES2070087B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPUESTOS DE FORMULA I, DONDE W, N, M, R1, R11 SE DEFINEN DETALLADAMENTE EN LA MEMORIA. ESTOS COMPUESTOS SON AGONISTAS POTENCIALES DE SEROTONINA (5-HT1) Y SON UTILES PARA EL TRATAMIENTO DE LA MIGRAÑA Y OTROS TRASTORNOS, SIENDO TAMBIEN UTILES COMO ANTIHIPERTENSORES DE ACCION CENTRAL Y VASODILATADORES.
ES9301804A 1993-08-13 1993-08-13 Derivados de indol Expired - Lifetime ES2070087B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9301804A ES2070087B1 (es) 1993-08-13 1993-08-13 Derivados de indol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9301804A ES2070087B1 (es) 1993-08-13 1993-08-13 Derivados de indol

Publications (2)

Publication Number Publication Date
ES2070087A1 ES2070087A1 (es) 1995-05-16
ES2070087B1 true ES2070087B1 (es) 1996-02-16

Family

ID=8282858

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9301804A Expired - Lifetime ES2070087B1 (es) 1993-08-13 1993-08-13 Derivados de indol

Country Status (1)

Country Link
ES (1) ES2070087B1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
AU646871B2 (en) * 1990-06-07 1994-03-10 Astrazeneca Uk Limited Therapeutic heterocyclic compounds
CA2094270C (en) * 1990-10-18 1997-01-21 Fumio Suzuki Xanthine derivatives
TW263508B (es) * 1991-02-12 1995-11-21 Pfizer
CZ281763B6 (cs) * 1992-04-07 1997-01-15 Pfizer Inc. Indolové deriváty představující 5-HT1 agonisty, způsob jejich přípravy, farmaceutické prostředky obsahující tyto látky, jejich použití a meziprodukty postupu přípravy

Also Published As

Publication number Publication date
ES2070087A1 (es) 1995-05-16

Similar Documents

Publication Publication Date Title
CR10370A (es) Derivados sustituidos de pirrolo-pirazol inhibidores de quinasa (divisional exp. 7880)
SE9903998D0 (sv) New compounds
FI963450A0 (fi) Morfoliinitakykiniinireseptoriantagonistien lääke-esiastetta
ID18883A (id) Pesaing 5-ht 1f
NO20005237L (no) Heterocyklisk substituerte amider anvendt som calpain- inhibitorer
ES2141913T3 (es) Agonistas y antagonistas de los receptores de la adenosina a1.
DE69737592D1 (de) Mittel gegen juckreiz
BR9106665A (pt) Derivados de quinuclidina
MX9302011A (es) Derivados de indol.
AR023777A1 (es) Nuevos compuestos
DE69724811D1 (de) Pentafluorobenzensulfonamide und analoge
DK0491664T3 (da) Indolderivater som serotonin-antagonister
MY132794A (en) Piperazine derivatives
AR028705A1 (es) Bis-arilsulfonas
ES2060818T3 (es) Derivados de indol, benzofurano y benzotiofeno sustituidos como inhibidores de la 5-lipooxigenasa.
ES2084996T3 (es) Piperazinas sustituidas utiles como agentes para el sistema nervioso central.
ES2181995T3 (es) Derivados de bencimidazol y uso como antagonistas del factor de liberacion de la corticotropina.
ES2166046T3 (es) Derivados de arilacrilamida como agonistas o antagonistas de 5ht1.
AR021695A1 (es) 4,5-pirazinoxindoles, composicion farmaceutica y uso
TR199700956T1 (xx) Indazolkarboksamidler.
AR024747A1 (es) Derivados de aminotiazoles, su preparacion y las composiciones farmaceuticas que los contienen.
DK1532131T3 (da) Motilid-forbindelser
AU5614198A (en) Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors
MX9700080A (es) Derivados de aril y heteroaril alcoxinaftaleno.
FI905957A0 (fi) Foerfarande foer framstaellning av substituerade cyklohexener, som verkar pao det centrala nervsystemet.